At the 2016 annual meeting of the American Association for Cancer Research (AACR) one topic that attracted a lot of attention and debate was the use of mouse models to guide cancer immunotherapy drug development strategy.

Dr Bernie Fox AACR 2016 New Orleans

Bernard A. Fox, PhD (pictured above) is Chief, Laboratory of Molecular and Tumor Immunology and holds the Harder Family Chair for Cancer Research at the Earle A. Chiles Research Institute at Providence Cancer Center. He’s also President and CEO of UbiVac.

You can follow him on Twitter at @BernardAFox.

A pioneer is someone who helps develop something new and prepares the way for others to follow.

We want to harness our immune system to fight and cure cancer. In this episode you’ll hear from two (of the many) pioneers in the field of cancer immunotherapy.

Dr Stephan Grupp CHOP

Dr Stephan Grupp (pictured above) from The Children’s Hospital of Philadelphia is leading the way in developing CAR T cell therapy for children with acute lymphoblastic leukemia (ALL). Dr Grupp is a Professor of Pediatrics at the University of Pennsylvania.